• Company
• Companies show mixed responses to patent term limitation law
• by Kim, Jin-Gu Dec 30, 2024 05:57am

• Company
• Generic drugs mkt heat up as GLP-1 obesity meds demand soar
• by Son, Hyung Min Dec 30, 2024 05:57am

• Company
• First RSV vaccine Arexvy Inj lands in Korea
• by Whang, byung-woo Dec 27, 2024 05:56am

• Company
• SK Bioscience and Sanofi sign contract to co-develop
• by Cha, Jihyun Dec 26, 2024 05:51am

• Company
• Daiichi Sankyo to build manufacturing facilities in China
• by Kim, Jin-Gu Dec 26, 2024 05:50am

• Company
• K-Bios seek drugs to be used in combination with ADCs
• by Son, Hyung Min Dec 26, 2024 05:50am

• Company
• Losartan prescription market has grown 15% in 3 years
• by Chon, Seung-Hyun Dec 26, 2024 05:50am

• Company
• Soyun Oh appointed to head Organon Malaysia
• by Whang, byung-woo Dec 24, 2024 06:22am

• Company
• SK Bioscience and Sanofi reinforce vaccine R&D partnership
• by Dec 24, 2024 06:22am

• Company
• Keytruda faces challenge from 'Steep Slope' CDRC
• by Moon, sung-ho Dec 24, 2024 06:21am